Evidence map›Paper›PMID 42355403›Full record

ArticleLife (Basel, Switzerland)2026

Cerebral Veins and Dural Sinuses Thrombosis: Data from a Monocentric Cohort Study of 55 Romanian Patients.

Dragos Catalin Jianu, Silviana Nina Jianu, Razvan Bertici, Nicoleta Iacob, Sergiu Florin Arnautu, Georgiana Munteanu, Traian Flavius Dan, Raphael Sadik, Tudor Nicolae Jianu, Any Axelerad and 5 more

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Dragos Catalin JianuFirst Division of Neurology, Department of Neurosciences, Victor Babes University of Medicine and Pharmacy, E. Murgu Sq., No. 2, 300041 Timisoara, Romania.ORCID 0000-0002-7827-818X
Silviana Nina JianuDepartment of Ophthalmology, Dr. Victor Popescu Military Emergency Hospital, 7 G. Lazar Ave., 300080 Timisoara, Romania.
Razvan BerticiFirst Division of Neurology, Department of Neurosciences, Victor Babes University of Medicine and Pharmacy, E. Murgu Sq., No. 2, 300041 Timisoara, Romania.
Nicoleta IacobDepartment of Multidetector Computed Tomography and Magnetic Resonance Imaging, Neuromed Diagnostic Imaging Centre, 300218 Timisoara, Romania.
Sergiu Florin ArnautuCentre for Cognitive Research in Neuropsychiatric Pathology (NeuroPsy-Cog), Department of Neurosciences, Victor Babes University of Medicine and Pharmacy, 156 L. Rebreanu Ave., 300736 Timisoara, Romania.
Georgiana MunteanuFirst Division of Neurology, Department of Neurosciences, Victor Babes University of Medicine and Pharmacy, E. Murgu Sq., No. 2, 300041 Timisoara, Romania.ORCID 0000-0002-6689-5017
Traian Flavius DanFirst Division of Neurology, Department of Neurosciences, Victor Babes University of Medicine and Pharmacy, E. Murgu Sq., No. 2, 300041 Timisoara, Romania.
Raphael SadikDepartment of Geriatrics-Rehabilitation, Riviera-Chablais Hospital, 3 Prairie Ave., 1800 Vevey, Switzerland.
Tudor Nicolae JianuFirst Division of Neurology, Department of Neurosciences, Victor Babes University of Medicine and Pharmacy, E. Murgu Sq., No. 2, 300041 Timisoara, Romania.
Any AxeleradCentre for Cognitive Research in Neuropsychiatric Pathology (NeuroPsy-Cog), Department of Neurosciences, Victor Babes University of Medicine and Pharmacy, 156 L. Rebreanu Ave., 300736 Timisoara, Romania.ORCID 0000-0002-8525-3554
Cristina TudoranCentre for Cognitive Research in Neuropsychiatric Pathology (NeuroPsy-Cog), Department of Neurosciences, Victor Babes University of Medicine and Pharmacy, 156 L. Rebreanu Ave., 300736 Timisoara, Romania.ORCID 0000-0002-7351-741X
Andrei Gheorghe Marius MotocCentre for Cognitive Research in Neuropsychiatric Pathology (NeuroPsy-Cog), Department of Neurosciences, Victor Babes University of Medicine and Pharmacy, 156 L. Rebreanu Ave., 300736 Timisoara, Romania.ORCID 0000-0001-7090-7677
Stefan StrilciucResearch Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Haţieganu University of Medicine and Pharmacy, 32-38 Gheorghe Marinescu St., 400347 Cluj-Napoca, Romania.
Dafin Fior MuresanuDepartment of Neurosciences, Iuliu Hațieganu University of Medicine and Pharmacy, No. 8 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
Ligia PetricaCentre for Cognitive Research in Neuropsychiatric Pathology (NeuroPsy-Cog), Department of Neurosciences, Victor Babes University of Medicine and Pharmacy, 156 L. Rebreanu Ave., 300736 Timisoara, Romania.ORCID 0000-0003-3138-3051

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral venous sinus thrombosis (CVST) is a rare form of stroke with heterogeneous clinical presentation and etiological profile. This study aimed to evaluate the demographic, clinical, imaging, etiological, treatment, and outcome characteristics of CVST in a Romanian population. We conducted a retrospective monocentric cohort study including 55 patients diagnosed over a six-year period in a tertiary neurological center. CVST accounted for 1.2% of all stroke cases, with an incidence of 13.75 per million per year. Gender distribution was relatively balanced, differing from international cohorts, and traditional female-specific risk factors were less prominent. Thrombophilia (68.6%) and infections (38.2%) were the most frequent etiologies. Younger patients were more frequently associated with thrombophilia, while a higher inflammatory response was observed in older individuals; additionally, female patients showed a higher prevalence of the MTHFR C677T mutation. Transverse and sigmoid sinuses were the most affected, while cavernous sinus involvement was more frequent than typically reported and associated with infections. At discharge, long-term anticoagulation was recommended in 67.3% of patients, tailored to underlying etiology and risk profile. Outcomes were favorable, with 70-80% achieving a modified Rankin Scale score ≤2 at discharge and over 90% at 90-day follow-up, despite inconsistent correlation with imaging findings. These results highlight the heterogeneous nature of CVST and the need for comprehensive, individualized evaluation and management.

Indexed as

anticoagulationcerebral venous sinus thrombosisclinical outcomesneuroimagingstrokethrombophilia

Identifiers

PMID42355403
PMCPMC13301528

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.